Clinical Trial Update: Comparison of Effects of Telmisartan and Valsartan on Neointima Volume in Diabetes [Phase 4]

View source ↗

Summary

A completed Phase 4 trial comparing telmisartan and valsartan on neointima volume in diabetes was conducted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus
• Hypertension

Drugs mentioned

• Telmisartan (Telmisartan)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Korea University Anam Hospital | Conditions: Hypertension, Diabetes | Phase 4 | Status: COMPLETED